Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in the Netherlands / NCT04241328
Recruiting Observational

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

NCT04241328 · tracked via the Priya Life Science Netherlands tracker
Sponsor
Medtronic Cardiac Surgery
Phase
Observational
Started
2020-01-09
Last updated
2026-07-30

Condition(s) studied

Cardiovascular Diseases

Study summary

The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Subject or legally authorized representative provides written data release and/or informed consent per institution and/or geographical requirements prior to discharge from participating registry hospital. * Subject will undergo or underwent a procedure in which an eligible Medtronic CS product is/was used. Exclusion Criteria: * Currently participating in an interventional drug or device study which may induce confounding factor(s) to the results from this Registry

Primary outcome measure(s)

Trial sites (14)

FacilityCityRegionStatus
AKH Wien Vienna Austria Recruiting
Ziekenhuis Oost-Limburg Genk Belgium Completed
UZ Leuven Leuven Belgium Completed
CHU d'Angers Angers France Completed
Clinique Claude Bernard Metz France Terminated
Uniklinik RWTH Aachen Aachen Germany Recruiting
Herz- und Diabeteszentrum NRW Bad Oeynhausen Germany Recruiting
Deutsches Herzzentrum München Munich Germany Recruiting
Onassis Hospital Athens Greece Active Not Recruiting
Catharina Ziekenhuis Eindhoven Netherlands Completed
Maastricht University Medical Center (MUMC+) Maastricht Netherlands Active Not Recruiting
St. Antonius Ziekenhuis Nieuwegein Netherlands Recruiting
Haukeland Universitetssjukehus Bergen Norway Suspended
Hospital Clinic Barcelona Barcelona Spain Completed

More Medtronic Cardiac Surgery trials in the Netherlands

Medtronic Cardiac Surgery PMCF Registry Recruiting
PERIGON Pivotal Trial Active, not recruiting

Other trials for the same condition

OPTImizing CArdiac REhabilitation by REfining Sleep and STress Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease Recruiting
Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation Recruiting
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN Active, not recruiting
Clinical Evaluation of EEG Device for the Triage of Stroke Patients in the Ambulance Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04241328 on ClinicalTrials.gov ↗ ← All trials in the Netherlands